Introduction
The transfer of expressible gene sequences into the body by infusion of vehicle cells modified ex vivo offers potential therapy for a wide spectrum of diseases. However, genetically modified vehicle cells capable of achieving reliable high-level, long-term, tissue-specific, and regulated expression of transduced genes are still under investigation. [1] [2] [3] Hematopoietic stem cells have been most widely used for this purpose because they are easily transplantable, stable, and undergo self-renewal. [3] [4] [5] However, difficulties with isolation, culture, transduction and stable gene expression limits their applicability. 3, 4 Peripheral blood lymphocytes, which are easy to transduce, culture, and transplant, have also been used as vehicles; however, they have a limited lifespan and do not target to a specific organ following infusion. 5, 6 Bone marrow stromal cells, which form an essential structural and functional component of the bone marrow microenvironment and are critical in hematopoiesis, [7] [8] [9] [10] may be an ideal vehicle for gene transfer. [9] [10] [11] Stromal cells can be cultured in vitro and expanded for prolonged periods. 12 Transduction efficiencies of up to 5% have been reported using electroporation. 11 Studies by Keating et al 13 following allogeneic transplantation in humans. Transplantation of bone marrow fibroblastoid stromal cells via the intravenous route has been reported in a murine model. 14, 15 However, other studies suggest host origin of the marrow stroma after allogeneic transplantation. 16 The discrepancy in origin of stroma after transplantation may originate from the conditioning regimen, the source of marrow stromal cells, and the culture conditions. [14] [15] [16] The engraftment characteristics of transplanted stromal cells and their localization in organs other than bone marrow are not known. Therefore, we studied efficiency of in vitro retroviral transduction and the in vivo characteristics of transduced stromal cells in a murine transplantation model. We also studied the possible derivation of hematopoietic cells from the transduced stromal cells as detected by PCR analysis of the peripheral blood cells of mice transplanted with transduced stromal cells.
Results
Stromal cell morphology After 3 weeks of culture, the bone marrow stromal cells formed a uniform adherent cell layer. The morphology of these cells, shown in Figure 1, endothelial cells have been reported earlier. 12 Investigation for the presence of primitive hematopoietic cells showed no c-kit ligand receptor positive cells on flow cytometric analysis confirming lack of contamination by hematopoietic progenitor cells (data not shown).
Transduction efficiency
Following transduction of stromal cells with the ␤-gal gene ( Figure 2 ) and subsequent culture, the transduction efficiency was determined by staining the cells for ␤-galactosidase activity. After one round of infection, the transduction efficiency, as determined by per cent of blue cells, was between 1 and 15%. The efficiency increased after three rounds of infection and reached a maximum of 5-40%.
Transduced cell engraftment
Mice transplanted with stromal cells with or without prior irradiation were evaluated for engraftment of transduced cells in various organs, 1 and 3 weeks after stromal cell infusion. Quantitative PCR of DNA samples from different organs showed no significant difference in the patterns of in vivo distribution of transduced stromal cells between previously irradiated (n = 3) and non-irradiated (n = 5) groups, as shown in Figure 3 . Both groups showed predominant targeting to the bone marrow and spleen, with the presence of a smaller number of transplanted cells in the liver, kidney and lungs. Blood samples were negative for the presence of transduced cells. In the irradiated mice, there were 3.9% transduced cells in the spleen and 1.8% in the bone marrow. In the nonirradiated mice, there were 4.1% transduced cells in the spleen and 1.7% in the bone marrow.
Distribution and lifespan of transplanted stromal cells
To determine the distribution and lifespan of transplanted stromal cells in recipient mice, a new group of mice were infused with the transduced stromal cells without prior irradiation. One to three mice were killed at 1 (n = 3), 3 (n = 3), 6 (n = 2), 9 (n = 2), 12 (n = 1) or 24 (n = 2) weeks after transplantation, and cells obtained from harvested organs were analyzed by PCR. As shown in Figure 4 , transduced stromal cells were present in all the organs examined, including the spleen, bone marrow, kidney, lung and liver. However, the majority of the cells were targeted to the spleen and bone marrow. Quantitative PCR demonstrated that between 3% and 5% of the cells in the spleen and bone marrow contained the ␤-gal gene, whereas the liver contained Ͻ1% transduced cells and the kidney and lung contained Ͻ0.2% transduced cells. At 24 weeks after infusion, the transduced stromal cells persisted in the same proportion in the spleen and bone marrow but declined in the kidney and lung. At all time-points, blood cells were negative for the presence of transduced cells. Stromal cells were cultured from bone marrow of transplanted mice and stained for ␤-galactosidase activity. As can be seen in Figure 5 , transduced transplanted cells mainly of fibroblastoid and macrophage type are seen in cells cultured from transplanted mice compared with no blue cells in control mice.
Self-renewal capacity
To demonstrate further the successful transfer of stromal cells and to investigate the self-renewal capacity of transplanted stromal cells, bone marrow cells were harvested from primary transplant recipients 3 weeks after the first stromal cell transplant. After washing with culture medium, non-fractionated bone marrow cells were injected into non-irradiated Balb/c mice (n = 3) via the tail vein at a dose of 10 7 cells per mouse. After 1-3 weeks, the mice were killed, and cells from harvested organs were analyzed by PCR. As shown in Figure 6 , cells transduced with the ␤-gal gene were present in the spleen, bone marrow, lung, kidney and liver in similar proportions as seen with primary stromal cell transplantation. As in primary recipients, transduced cells were not present in the blood of secondary recipients at any time after transplantation.
Discussion
The potential for engraftment of stromal cells following transplantation has been debated for the last 20 years with some reports suggesting transplantability of donor stromal cells in mice 14, 15 and humans 13 and other reports suggesting that the cells are of recipient origin. [16] [17] [18] All past human and murine studies were based on sex chromosome differences or subtle surface phenotypic differences between donors and recipients. In the present study, gene transduction makes detection of donor cells specific and reliable, and, within the limitations of PCR, quantitative.
An important factor that has not been previously studied is the targeting of transduced stromal cells. In the absence of gene marking, all previous studies have analyzed engraftment of donor stromal cells in the bone marrow. 13, 15, 16 Results of our study indicate that stromal cells may have special targeting to bone marrow and, in the case of mice, to other hematopoietic organs (spleen and liver) as well. It can be speculated that this preferential localization may be related to adhesion molecules on stromal cells that may allow them to anchor to the hematopoietic cells. A small number of cells lodge in other organs, such as the kidney and lung, and survive for a prolonged period of time. The characteristics and behavior of these cells in the lung and kidney need to be studied further.
In the case of whole bone marrow transplant, hematopoietic cells require a special microenvironment for their growth, and, thus, with the help of adhesion molecules on the cells they lodge in the bone marrow. 19 However, it is possible that stromal cells do not need any other support and are thus able to survive in hematopoietic and non-hematopoietic organs. Various adhesion molecules have also been reported on stromal cells. 9, 20 In the past, stromal adhesion molecules were considered important for effecting and keeping the hematopoietic cells in the bone marrow. It is likely that the same or similar adhesion molecules on stromal cells may be important in the targeting of stromal cells following transplantation.
Another issue raised by this study is the absence of transduced cells in the blood. This study showed that transduced cells disappeared from the circulation within 1 week after transplantation, which suggests rapid attachment to appropriate organs, probably through surface receptors. However, the absence of any circulating hematopoietic cells marked with provirus for up to 24 weeks after transplantation suggests thatt the infused stromal cells did not contain any hematopoietic cells and that hematopoietic elements are not generated from stromal cells under these conditions.
For clinical use, the development of a cell population in which 100% of the cells express the desired gene would be advantageous. With the culture conditions used in this study we achieved over 5% retroviral transduction efficiency of marrow stromal cells. Although the a b
Figure 5 Bone marrow stromal cells were cultured from mice transplanted with transduced cells and from control mice. X-gal staining of these cells at 2 weeks shows the presence of transduced blue stromal cells from mice transplanted with ␤-galactosidase transduced cells (b) with the absence of staining in stromal cells from control mice (a).

Figure 6 Bone marrow cells were collected 3 weeks after mice were transplanted with transduced stromal cells. These cells were reinfused in a second recipient, and 3 weeks later, various organs from these secondary transplanted mice were studied by PCR which confirms similar engraftment characteristics.
current experimental scheme did not utilize long-term culture conditions, it would allow selection of the transduced cells by a drug-resistant gene to obtain a pure transduced cell population. The role of radiation before transplantation has been previously discussed. 21 It is believed that prior irradiation would remove the majority of the recipient bone marrow cells, and possibly the stromal cells, from the bone marrow space, thereby facilitating engraftment of transplanted cells. However, we observed no significant difference between the irradiated and non-irradiated mice with respect to degree of engraftment at 1 and 3 weeks after transplantation. We hypothesize that stromal cells cultured in vitro have a proliferative advantage enabling them to engraft in the bone marrow without the need to obliterate the recipient bone marrow and stromal cells. The ability of stromal cells to be easily cultured, transduced and transplanted, and their target specificity to hematopoietic organs make them an attractive vehicle for gene transfer. Their localization to hematopoietic tissues indicates their potential use in accelerating hematopoietic recovery following bone marrow transplantation and in helping marrow regeneration through local production of cytokines. Transduction of stromal cells with various functional genes has been reported, [22] [23] [24] [25] however, their tissue localization has not been studied. Transduction of stromal cells with a gene that inhibits HIV-1 replication (an RRE decoy) has been reported by Bahner et al 26 and their ability to inhibit HIV replication has been demonstrated in vitro. This shows one of the potential application of stromal cell as a gene transfer vehicle. These studies suggest that stromal cells may be an ideal cell system for transferring genes that produce proteins for systemic applications, including coagulation factors, cytokines, enzymes such as ␣-1 antitrypsin and glucocerebrosidase and proteins with antitumor effects, such as CD16 and anti-infection agents. This type of gene transfer would also be helpful in treating disorders affecting the bone marrow microenvironment, such as myelofibrosis, late bone marrow graft failure, and toxicity from chemotherapy.
It is important to note that transplantability of various cells in the murine model has not always correlated with the human model. Further studies are needed to define the role of various surface molecules in the transplantability of stromal cells. Our current study provides a basis for future investigations and clearly indicates the potential of using stromal cells as a vehicle for gene transfer.
Materials and methods
Animals
Balb/c mice (Harlan Sprague-Dawley, Indianapolis, IN, USA), aged 6-8 weeks were used. Bone marrow cells were obtained by flushing femora and tibiae with RPMI-1640 medium (GIBCO BRL, Grand Island, NY, USA) in a 1-ml syringe with a 23-gauge needle. 13 After preparing single-cell suspensions, cells were resuspended in RPMI-1640 enriched with 10% horse serum (Sigma Chemical, St Louis, MO, USA), 10% bovine serum (GIBCO BRL) and 1% l-glutamine, at a concentration of 1 × 10 6 cells/ml.
Retroviral vector
The retroviral construct, RS10991, was derived from the LNL6 Moloney murine leukemia virus vector, as described previously. 27 This vector contains the human cytomegalovirus (CMV) immediate-early enhancer/ promoter, which drives expression of the E. coli ␤-gal gene, the internal ribosomal entry site (IRES) from the 5′-untranslated region of the encephalomyocarditis virus, and the dihydrofolate reductase (dhfr) gene, which confers methotrexate resistance. The IRES allows the downstream dhfr gene to initiate translation in a cap-independent fashion (Figure 1) . After transfecting the GP+envAM12 retroviral packaging cell line with the RS10991 construct, methotrexate-resistant clones were selected after 14 days of culture in medium containing 250 nm methotrexate (Sigma Chemical). Each methotrexate-resistant clone was expanded and then titrated for retroviral activity by transducing murine NIH 3T3 fibroblasts and staining with X-gal 48 h later. A high-titer clone packaging the RS10991 construct was selected for the supernatant harvest. Confluent dishes of the hightiter clone were replated with fresh medium (lacking methotrexate), and the clones were allowed to produce infection-competent/replication-deficient retroviral particles for 18 h. The retroviral supernatant was harvested and filtered through a 0.45-m cellulose acetate syringe filter (Schleicher & Schuell, Keene, NH, USA) and stored at −20°C until use. The retroviral titer used in this work was 2 × 10 5 CFU/ml.
Stromal cell culture
Stromal cells were cultured using methods previously described. 12, 28 Briefly, 10 7 cells, resuspended in 10 ml of the medium described above, were plated in 100-mm dishes and incubated at 37°C in 5% CO 2 . At weekly intervals the cultures were fed by replacing 50% of the supernatant with fresh culture medium. When confluent, cells were trypsinized and split at a ratio of 3:1. All nonadherent cells were then removed, and the remaining cells were split at least four times before transduction. Cells, following culture, were stained with fluorescence-labeled antic-kit ligand receptor antibody and analyzed by flow cytometry for the presence of contaminating hematopoietic progenitor cells which stained positive for c-kit ligand receptor.
Stromal cell transduction
After trypsinization and replating, stromal cells were allowed to grow until reaching 20-30% confluency. The supernatant was then removed, the cells were washed twice with PBS, and 10 ml of viral supernatant at a MOI of 2-5:1 was added in the presence of 4 g/ml polybrene. Cells were cultured at 37°C for 2 h, washed with PBS, and fed with fresh culture medium. This infection process was repeated a total of three times to achieve a higher transduction efficiency. Following further culture, cells were washed three times with PBS, fixed with formaldehyde in PBS and stained overnight at 37°C with 5-bromo-4-chloro-3-indolyl-␤-d-galactopyranoside (X-gal; Stratagene, La Jolla, CA, USA) to determine the transduction efficiency.
Stromal cell transplantation
Balb/c mice, aged 4-6 weeks, were used for stromal cell transplantation. Half of the mice were pre-irradiated with 450 cGy in a single fraction from a cesium-137 source. The other group of mice received no radiation. The transduced stromal cells in 0.2 ml PBS were then administered by tail vein injection at a dose of 2 × 10 6 cells per mouse. At 1, 3, 6, 9, 12, 15 and 24 weeks after transplantation, one to three mice were killed by cervical dislocation, and the bone marrow, lung, kidney and spleen were harvested from each animal. DNA was extracted from these organs using a standard method. 29 Before mice were killed 200 l of blood was obtained by retro-orbital bleed after anesthetizing the animals with metofane. Stromal cells were cultured from transplanted mice as described above and at 2 weeks stained with X-gal for detection of transduced cells.
Quantitative PCR
The percentage of transduced cells obtained from the harvested mouse organs was determined using a quantitative multiplex PCR protocol, 30 using as the forward primer, 5′ ATTGGCCTGAACTGCCAGCT 3′, and as the reverse primer, 5′ CTATGGCTCGTACTCTATAGG 3′ for the ␤-gal gene and 5′ CATTGTGATGGACTCCGG AGACGG 3′ and 5′ CATCTCCTGCTCGAAGTC TAGAGC 3′ for actin gene. PCR reactions were carried out by adding a 100 g sample of the DNA to a mixture containing 1.25 U AmpliTaq (Perkin-Elmer Cetus, Norwalk, CT, USA), 200 m of each dNTP, 0.5 m of each primer, and 1× concentration of PCR buffer, in a total volume of 50 l. PCR was performed for 30 cycles of 94°C for 1 min, 61°C for 2 min, and 72°C for 2 min, using a Perkin-Elmer Cetus ThermaCyclercycler 480. Reaction products were separated on a 2% agarose gel and transferred to nylon membranes using the standard Southern blot technique. 31 Blots were probed by the random priming method using the ␤-gal fragment labeled with phosphorus-32 at a high specific activity (Pharmacia, Piscataway, NJ, USA) and were visualized by exposure to Xray film (Fuji, Japan). Each quantitative multiplex PCR experiment was calibrated by construction of standard curves that had been generated by simultaneous amplification of serial dilutions of DNA from an NIH 3T3 cell line containing a single integrated RS10991 ␤-gal provirus.
